Intralase Corp Sample Contracts

Intralase Corp – FOR IMMEDIATE RELEASE Advanced Medical Optics, Inc. IntraLase Corp. Investors: Investors and Media: Sheree Aronson Krista Mallory (January 10th, 2007)

(SANTA ANA, CA), January 8, 2007 – Advanced Medical Optics, Inc. (AMO) [NYSE: EYE], a global ophthalmic surgical and eye care products company, and IntraLase Corp. [Nasdaq: ILSE], today announced that the two companies have entered into a definitive agreement for AMO to acquire IntraLase for approximately $808 million in cash.

Intralase Corp – AGREEMENT AND PLAN OF MERGER BY AND AMONG ADVANCED MEDICAL OPTICS, INC. IRONMAN MERGER CORPORATION and INTRALASE CORP. Dated as of January 5, 2007 (January 10th, 2007)

AGREEMENT AND PLAN OF MERGER, dated as of January 5, 2007 (this “Agreement”), by and among Advanced Medical Optics, Inc., a Delaware corporation (“Parent”), Ironman Merger Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and IntraLase Corp., a Delaware corporation (the “Company”).

Intralase Corp – INTRALASE CORP. AWARDED CONTRACT FROM DEFENSE LOGISTICS AGENCY Contract Award Across all Branches of U.S. Military Firmly Establishes IntraLase as LASIK Technology of Choice (December 27th, 2006)

IRVINE, Calif., December 22, 2006 – IntraLase Corp. (NASDAQ: ILSE) today announced today that on December 20, 2006 it was awarded a contract for up to $45 million from the Defense Logistics Agency for IntraLase® FS lasers, procedures, maintenance and support for the U.S. Army, Navy, Air Force, Marine Corps, and Federal civilian agencies. The award establishes a five year indefinite-delivery-quantity contract with the possibility of five additional one year options.

Intralase Corp – INTRALASE CORP. AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN (August 1st, 2006)

This AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN (the “Plan”) is hereby established by INTRALASE CORP., a Delaware corporation (the “Company”), and adopted by its Board of Directors as of May 23, 2006 (the “Effective Date”).

Intralase Corp – EMPLOYMENT AGREEMENT (May 9th, 2006)

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on the 15th day of February, 2006 with an effective date of the 11th day of April, 2006, by and between INTRALASE CORP., a Delaware corporation (the “Company”) and ROBERT PALMISANO (hereinafter “Executive”).

Intralase Corp – INTRALASE RECORDS PROFITABLE 2005 SECOND QUARTER ON STRONG LASER PLACEMENTS, 76% INCREASE IN PER-PROCEDURE UNIT SALES Revenues Rise 45% to $23 Million; Sale of 39 Lasers Boosts Worldwide Installed Base to 293 (August 3rd, 2005)

IRVINE, Calif.—(BUSINESS WIRE)—July 28, 2005—IntraLase Corp. (Nasdaq: ILSE) today reported strong gains in revenue, its installed base, and per-procedure unit sales for the second quarter and six months ended June 30, 2005.

Intralase Corp – INTRALASE POSTS PROFITABLE 2005 FIRST QUARTER ON RECORD LASER PLACEMENTS, STRONG PROCEDURE REVENUES Revenues Exceed $21 Million, More Than Double a Year Ago; Sale of 39 Lasers Boosts Worldwide Installed Base to 254 (May 4th, 2005)

IRVINE, Calif.—(BUSINESS WIRE)—April 28, 2005—IntraLase Corp. (Nasdaq: ILSE) today reported significant gains in revenue and installed base for the first quarter ended March 31, 2005, as the company’s INTRALASE® FS laser continues to gain acceptance among ophthalmologists worldwide. The strong revenue growth drove increased gross margin and improved operating leverage, which produced the first profitable quarter in the company’s history.

Intralase Corp – IntraLase Granted Temporary Restraining Order in Escalon Litigation; License Agreement Remains in Force (April 11th, 2005)

IRVINE, Calif.—(BUSINESS WIRE)—April 8, 2005—IntraLase Corp. (Nasdaq: ILSE) announced today that on April 7, 2005, the U.S. District Court for the Central District of California granted IntraLase’s request for a temporary restraining order that prohibits Escalon Medical Corp. (Nasdaq: ESMC) from taking any action to terminate its licensing agreement with IntraLase. The Court will conduct a hearing on this matter on April 25, 2005, and IntraLase is confident that it will prevail. IntraLase has arranged a surety bond as required by the Court’s order and will timely file the bond with the Court.

Intralase Corp – INTRALASE CORP. CHANGE OF CONTROL SEVERANCE AGREEMENT (March 29th, 2005)

This agreement is entered into between IntraLase Corp (the “Company,” which term shall include any successor by merger, consolidation, sale of substantially all of the Company’s assets or otherwise) and James Lightman (“Executive”) effective as of the fourteenth day of February, 2005 (“Effective Date”).

Intralase Corp – 9701 JERONIMO ROAD OFFICE LEASE (March 29th, 2005)

This Office Lease, which includes the preceding Summary attached hereto and incorporated herein by this reference (the Office Lease and Summary to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between 9701 JERONIMO HOLDINGS, LLC, a California limited liability company (“Landlord”) and INTRALASE CORP., a Delaware corporation (“Tenant”).

Intralase Corp – INTRALASE EXECUTIVE INCENTIVE COMPENSATION PLAN (December 28th, 2004)
Intralase Corp – Contact: Kimberly Goolsby (December 13th, 2004)

IRVINE, Calif. (Dec. 8, 2004) – IntraLase Corp. (NASDAQ: ILSE) announced today that Prof. Dr. med Thomas Neuhann, an international cataract and refractive surgery pioneer, has purchased an INTRALASE FS Laser for use in his Munich ophthalmic practice, the alz eye clinic munich. This sale further establishes the INTRALASE FS laser in the very technologically advanced European market, extending the technology’s global reputation for improved safety, precision and visual outcomes over blade-based microkeratomes historically used in LASIK (laser-assisted in-situ keratomileusis) surgery.

Intralase Corp – INTRALASE REPORTS THIRD QUARTER 2004 REVENUES DOUBLED OVER THIRD QUARTER 2003 Increases Led by Higher Laser Placements and Rise in Sales of Per-Procedure Disposables (November 2nd, 2004)

IRVINE, Calif. – (BUSINESS WIRE) – October 28, 2004, IntraLase Corp., (NASDAQ:ILSE) reported today consolidated revenues for the third quarter ended September 30, 2004 more than doubled over the comparable prior-year period to $15.5 million. Revenues benefited from continued growth in demand for INTRALASE FS® lasers, with the company placing for sale or lease 27 lasers in the quarter compared to 14 sales or leases in the third quarter of 2003. Laser revenues were $8.6 million versus $3.4 million in the comparable quarter a year ago. The company’s expanding base of installed lasers resulted in an increase in per-procedure disposable patient interface revenues, which also more than doubled to $5.7 million in the third quarter of 2004 versus $2.6 million in the prior-year period. Per-procedure revenues stem from disposable patient interfaces used to create corneal flaps in the first step of each LASIK procedure. Revenues from laser maintenance contracts totaled $1.2 million for the third

Intralase Corp – AMENDMENT TO “LICENSE AGREEMENT MICHIGAN FILE 1509 TECHNOLOGY” BETWEEN THE REGENTS OF THE UNIVERSITY OF MICHIGAN AND INTRALASE CORP. (August 24th, 2004)

This Amendment to “License Agreement Michigan File 1509 Technology” (hereinafter “1509 License Agreement”) is made and entered into as of this 23rd day of January 2003 (“Effective Date”), by and between the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“Michigan”), and IntraLase Corp., a Delaware corporation (“Licensee”).

Intralase Corp – AMENDED AND RESTATED LICENSE AGREEMENT (August 24th, 2004)

This is a License Agreement between IntraLase, Inc., a Delaware corporation, with offices located at 30 Hughes, Suite 208, Irvine, California 92618 (“LICENSEE”), and Escalon Medical Corp., a Delaware corporation (“ESCALON”). This Agreement amends and restates that certain License Agreement dated October 23, 1997 by and between LICENSEE and ESCALON. This Agreement is effective as of the date executed by both LICENSEE and ESCALON (the “Effective Date”).

Intralase Corp – LICENSE AGREEMENT (August 24th, 2004)

This License Agreement (“Agreement”), effective as of March 16, 2000 (the “Effective Date”), is entered into by and between Shui Lai (“Licensor”), and IntraLase Corp., a Delaware corporation (“IntraLase”).

Intralase Corp – IntraLase Corp. [ ] Shares Common Stock UNDERWRITING AGREEMENT dated [ ], 2004 Banc of America Securities LLC Wachovia Capital Markets, LLC First Albany Capital Inc. ThinkEquity Partners LLC (August 3rd, 2004)
Intralase Corp – AMENDED AND RESTATED LICENSE AND SETTLEMENT AGREEEMENT MICHIGAN FILES 939, 1387, 1509, and 1662 (August 3rd, 2004)

This is an Agreement between IntraLase Corp., a corporation incorporated in the State of Delaware, with offices located at 3 Morgan, Irvine, California (“LICENSEE”), and the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“MICHIGAN”). This amended and restated license and settlement agreement (the “Agreement”) is effective as of June 28, 2004 (the “Effective Date”). LICENSEE and MICHIGAN agree as follows:

Intralase Corp – INTRALASE CORP. THIRD AMENDED AND RESTATED FOUNDERS’ AGREEMENT (August 3rd, 2004)

This Third Amended and Restated Founders’ Agreement (this “Agreement”) is entered into November , 2002, by and among IntraLase Corp., a Delaware corporation, with offices located at 3 Morgan Irvine, CA 92618, Irvine, California 92618 (the “Corporation”); Ronald M. Kurtz and Jennifer Simpson, and Tibor Juhasz (each individually a “Founder” and collectively the “Founders”).

Intralase Corp – INTRALASE CORP. EMPLOYEE STOCK PURCHASE PLAN (August 3rd, 2004)

This EMPLOYEE STOCK PURCHASE PLAN (the “Plan”) is hereby established by IntraLase Corp., a Delaware corporation (the “Company”) effective May 27, 2004 (the “Effective Date”).

Intralase Corp – INTRALASE CORP. 2004 STOCK INCENTIVE PLAN (July 13th, 2004)

This 2004 STOCK INCENTIVE PLAN (the “Plan”) is hereby established by INTRALASE CORP., a Delaware corporation (the “Company”), and adopted by its Board of Directors as of May 27, 2004 (the “Effective Date”).

Intralase Corp – INTRALASE CORP. CODE OF BUSINESS AND ETHICAL CONDUCT (July 13th, 2004)
Intralase Corp – AMENDMENT TO “LICENSE AGREEMENT MICHIGAN FILE 1509 TECHNOLOGY” BETWEEN THE REGENTS OF THE UNIVERSITY OF MICHIGAN AND INTRALASE CORP. (July 13th, 2004)

This Amendment to “License Agreement Michigan File 1509 Technology” (hereinafter “1509 License Agreement”) is made and entered into as of this 23rd day of January 2003 (“Effective Date”), by and between the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“Michigan”), and IntraLase Corp., a Delaware corporation (“Licensee”).

Intralase Corp – INTRALASE CORP. STOCK OPTION AGREEMENT (July 13th, 2004)

This Stock Option Agreement (the “Agreement”) is entered into as of , 200 , by and between IntraLase Corp., a Delaware corporation (the “Company”), and (the “Optionee”) pursuant to the Company’s 2004 Stock Incentive Plan (the “Plan”). Any capitalized term not defined herein shall have the same meaning ascribed to it in the Plan.

Intralase Corp – EMPLOYMENT AGREEMENT (July 13th, 2004)

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of the 10th day of April, 2003, by and between INTRALASE CORP., a Delaware corporation (the “Company”) and ROBERT PALMISANO (hereinafter “Executive”).

Intralase Corp – INDUSTRIAL LEASE (Single Tenant; Net) Between THE IRVINE COMPANY And INTRALASE CORP. (July 13th, 2004)

THIS LEASE is made as of the 7th day of September, 2000, by and between THE IRVINE COMPANY, a Delaware corporation, hereafter called “Landlord,” and INTRALASE CORP., a Delaware corporation, hereinafter called “Tenant.”

Intralase Corp – SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTRALASE CORP. (Incorporated September 29, 1997) (July 13th, 2004)

FIRST: She is the duly elected and acting Chief Financial Officer of IntraLase Corp., a Delaware corporation (the “Corporation”).

Intralase Corp – LICENSE AGREEMENT MICHIGAN FILE 939 TECHNOLOGY (July 13th, 2004)

This is an Agreement between IntraLase Corp., a corporation incorporated in the State of Delaware, with offices located at 245 North Main Street, Ann Arbor, Michigan 48104 (“LICENSEE”), and the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“MICHIGAN”). This Agreement is effective as of the date executed by both LICENSEE and MICHIGAN (the “Effective Date”). LICENSEE and MICHIGAN agree as follows:

Intralase Corp – Contract (July 13th, 2004)

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAW, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 AND AN EXEMPTION UNDER APPLICABLE STATE LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

Intralase Corp – PATENT LICENSE AGREEMENT between AGERE SYSTEMS GUARDIAN CORPORATION and INTRALASE CORP. Effective December 31, 2001 Relating to LASER OSCILLATOR SUBSYSTEMS (July 13th, 2004)

Effective December 31, 2001, (“Effective Date”) Agere Systems Guardian Corporation (“AGERE”), a Delaware corporation having an office at 9333 S. John Young Parkway, Orlando, Florida 32819-8698, and INTRALASE CORP., a Delaware corporation, (“INTRALASE”), having an office at 3 Morgan, Irvine, California, 92618, USA, agree as follows*:

Intralase Corp – LICENSE AGREEMENT (July 13th, 2004)

This License Agreement (“Agreement”), effective as of March 16, 2000 (the “Effective Date”), is entered into by and between Shui Lai (“Licensor”), and IntraLase Corp., a Delaware corporation (“IntraLase”).

Intralase Corp – INTRALASE CORP. EMPLOYEE STOCK PURCHASE PLAN (July 13th, 2004)

This EMPLOYEE STOCK PURCHASE PLAN (the “Plan”) is hereby established by IntraLase Corp., a Delaware corporation (the “Company”) effective May 27, 2004 (the “Effective Date”).

Intralase Corp – Contract (July 13th, 2004)

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAW, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 AND AN EXEMPTION UNDER APPLICABLE STATE LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

Intralase Corp – AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT (July 13th, 2004)

THIS AMENDMENT NO. 1 to that certain Amended and Restated License Agreement dated October 17, 2000, by and between IntraLase, Inc. (“LICENSEE”) and Escalon Medical Corporation (“ESCALON”) (the “License Agreement”) is effective as of the date executed by both LICENSEE and ESCALON (the “Effective Date”).

Intralase Corp – SECOND AMENDED AND RESTATED BYLAWS OF INTRALASE CORP. (AMENDED AND RESTATED , 2004) (July 13th, 2004)